What happened next surprised nobody at AstraZeneca. Within weeks, the company’s hard-charging CEO, Pascal Soriot, inserted the company into the front of the race to supply a game-changing vaccine.

AstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to almost double ...

This morning in New York, new AstraZeneca chief executive Pascal Soriot is telling investors how he is going to turn around the company that has had the absolute worst track record in research and ...

The probe centers around AstraZeneca’s eight or nine employees, Soriot said in a Bloomberg TV interview, noting that the firm employs 12,000 people in the country.

Unless you’ve been on vacation in the Amazon or doing research in the Antarctic you’ve heard the reports: AstraZeneca chief exec Pascal Soriot was said to have signed on as the new chief at Teva.

AstraZeneca’s Pascal Soriot is no stranger to shareholder scrutiny—especially when it comes to the longtime CEO’s pay. But the latest campaign against his re-election is nothing short of ...

AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why the drugmaker believes it can almost double revenue by 2030. "Biology is complicated, and we're never sure ...

Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...

LONDON (Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca said on Friday its chief executive, Pascal Soriot, would host a results call with reporters on July 27, after refusing to comment ...

Pascal Soriot suggested during the 2023 STAT Future Summit that Medicare should start the clock once a drug loses its “orphan” status. Skip to Main Content. Donald Trump. FDA.

CEO Pascal Soriot assures compliance with Chinese regulations and cooperation with the investigation. Chinese authorities have detained AstraZeneca employees amid a probe into potential data ...